Five-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, First-in-Human Study
Ian T Meredith, John Ormiston, Robert Whitbourn, I Patrick Kay, David Muller, Donald E Cutlip
Catheterization and Cardiovascular Interventions | WILEY | Published : 2009
Conflict of interest: Prof. Ian T. Meredith serve as a consultant to Boston Scientific and Medtronic CardioVascular. Dr. Ormiston serves on advisory boards for Abbott Vascular and Boston Scientific. Dr. Whitbourn has received research/grant support from Abbott Vascular, Boston Scientific, and Medtronic CardioVascular. Dr. Muller has received research/grant support from Abbott Vascular and Medtronic CardioVascular. Dr. Kay and Dr. Cutlip have no conflicts to report.